AU2011242496C1 - Cell culture medium comprising small peptides - Google Patents

Cell culture medium comprising small peptides Download PDF

Info

Publication number
AU2011242496C1
AU2011242496C1 AU2011242496A AU2011242496A AU2011242496C1 AU 2011242496 C1 AU2011242496 C1 AU 2011242496C1 AU 2011242496 A AU2011242496 A AU 2011242496A AU 2011242496 A AU2011242496 A AU 2011242496A AU 2011242496 C1 AU2011242496 C1 AU 2011242496C1
Authority
AU
Australia
Prior art keywords
cells
cell
cell culture
feed
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011242496A
Other languages
English (en)
Other versions
AU2011242496A1 (en
AU2011242496B2 (en
Inventor
Shawn Barrett
Scott Jacobia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44816118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2011242496(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Publication of AU2011242496A1 publication Critical patent/AU2011242496A1/en
Application granted granted Critical
Publication of AU2011242496B2 publication Critical patent/AU2011242496B2/en
Priority to AU2016200611A priority Critical patent/AU2016200611A1/en
Priority to AU2016256736A priority patent/AU2016256736B2/en
Publication of AU2011242496C1 publication Critical patent/AU2011242496C1/en
Priority to AU2018202612A priority patent/AU2018202612B2/en
Priority to AU2021200418A priority patent/AU2021200418B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2011242496A 2010-04-23 2011-04-22 Cell culture medium comprising small peptides Active AU2011242496C1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2016200611A AU2016200611A1 (en) 2010-04-23 2016-02-01 Cell culture medium comprising small peptides
AU2016256736A AU2016256736B2 (en) 2010-04-23 2016-11-09 Cell culture medium comprising small peptides
AU2018202612A AU2018202612B2 (en) 2010-04-23 2018-04-13 Cell culture medium comprising small peptides
AU2021200418A AU2021200418B2 (en) 2010-04-23 2021-01-22 Cell culture medium comprising small peptides

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32764410P 2010-04-23 2010-04-23
US61/327,644 2010-04-23
US13/092,016 US20110262965A1 (en) 2010-04-23 2011-04-21 Cell culture medium comprising small peptides
US13/092,016 2011-04-21
PCT/US2011/033630 WO2011133902A2 (en) 2010-04-23 2011-04-22 Cell culture medium comprising small peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016200611A Division AU2016200611A1 (en) 2010-04-23 2016-02-01 Cell culture medium comprising small peptides

Publications (3)

Publication Number Publication Date
AU2011242496A1 AU2011242496A1 (en) 2012-10-25
AU2011242496B2 AU2011242496B2 (en) 2015-11-19
AU2011242496C1 true AU2011242496C1 (en) 2017-03-09

Family

ID=44816118

Family Applications (6)

Application Number Title Priority Date Filing Date
AU2011242496A Active AU2011242496C1 (en) 2010-04-23 2011-04-22 Cell culture medium comprising small peptides
AU2016200611A Abandoned AU2016200611A1 (en) 2010-04-23 2016-02-01 Cell culture medium comprising small peptides
AU2016256736A Active AU2016256736B2 (en) 2010-04-23 2016-11-09 Cell culture medium comprising small peptides
AU2018202222A Abandoned AU2018202222A1 (en) 2010-04-23 2018-03-28 Cell culture medium comprising small peptides
AU2018202612A Active AU2018202612B2 (en) 2010-04-23 2018-04-13 Cell culture medium comprising small peptides
AU2021200418A Active AU2021200418B2 (en) 2010-04-23 2021-01-22 Cell culture medium comprising small peptides

Family Applications After (5)

Application Number Title Priority Date Filing Date
AU2016200611A Abandoned AU2016200611A1 (en) 2010-04-23 2016-02-01 Cell culture medium comprising small peptides
AU2016256736A Active AU2016256736B2 (en) 2010-04-23 2016-11-09 Cell culture medium comprising small peptides
AU2018202222A Abandoned AU2018202222A1 (en) 2010-04-23 2018-03-28 Cell culture medium comprising small peptides
AU2018202612A Active AU2018202612B2 (en) 2010-04-23 2018-04-13 Cell culture medium comprising small peptides
AU2021200418A Active AU2021200418B2 (en) 2010-04-23 2021-01-22 Cell culture medium comprising small peptides

Country Status (10)

Country Link
US (6) US20110262965A1 (OSRAM)
EP (4) EP2561065B1 (OSRAM)
JP (7) JP6016783B2 (OSRAM)
KR (6) KR102264580B1 (OSRAM)
CN (3) CN110205282B (OSRAM)
AU (6) AU2011242496C1 (OSRAM)
DE (1) DE202011110859U1 (OSRAM)
DK (3) DK2561065T3 (OSRAM)
SG (3) SG10201609347RA (OSRAM)
WO (1) WO2011133902A2 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10793827B2 (en) 2010-04-23 2020-10-06 Life Technologies Corporation Cell culture medium comprising small peptides

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012017925A1 (ja) * 2010-08-02 2012-02-09 協和発酵キリン株式会社 物質の製造方法
EP2601287B1 (en) 2010-08-05 2015-01-07 Amgen Inc. Dipeptides to enhance yield and viability from cell cultures
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
EP3702442B1 (en) 2011-12-22 2025-06-25 Life Technologies Corporation Cell culture media and methods
CN102533634A (zh) * 2012-02-22 2012-07-04 江阴剑桥生物技术有限公司 Cho细胞无血清无蛋白化学培养基
CN104334714A (zh) 2012-03-30 2015-02-04 味之素株式会社 含硫酸化化合物的干细胞增殖用培养基
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
BR112014027378A2 (pt) * 2012-05-02 2017-06-27 Life Technologies Corp expressão transiente de alto rendimento em células de mamíferos usando pareamento exclusivo de crescimento de alta densidade e meio de transfecção e potenciadores de expressão
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
JP6190205B2 (ja) * 2013-08-08 2017-08-30 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株、その製造方法及び培地
JP6195191B2 (ja) * 2013-08-08 2017-09-13 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株を用いた組換えタンパク質の製造方法
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
CN104593318B (zh) * 2013-10-31 2018-05-04 中国食品发酵工业研究院 一种用于细胞培养基的玉米活性肽添加剂
US9534026B2 (en) * 2013-10-31 2017-01-03 China National Research Institute Of Food & Fermentation Industries Corn active peptide additive for cell culture medium
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
EP3129463B1 (en) 2014-04-10 2021-05-26 Bayer Healthcare LLC Compounded media powder formulation and method of preparation of liquid medium for cell culture
EP3142486B1 (en) * 2014-05-14 2026-03-11 Boehringer Ingelheim Vetmedica GmbH Methods for freeze-drying and rehydrating biologics
AU2015277230A1 (en) * 2014-06-18 2017-01-05 Medimmune, Llc Cell culture methods and media comprising N-acetylcysteine
MX383347B (es) 2014-08-11 2025-03-13 Hoffmann La Roche Método para incrementar la velocidad de producción específica de células eucariotas.
WO2016192830A1 (en) * 2015-05-29 2016-12-08 Merck Patent Gmbh Deep eutectic solvents and/or ionic liquids in cell culture media
US20180312802A1 (en) * 2015-11-02 2018-11-01 Ares Trading S.A. Methods for modulating production profiles of recombinant proteins in perfusion mode
SG11201806335RA (en) * 2016-02-22 2018-09-27 Agency Science Tech & Res Cell culture medium
CN107760651A (zh) * 2016-08-23 2018-03-06 四川科伦博泰生物医药股份有限公司 一种细胞培养基及生产蛋白质的方法
ES2901134T3 (es) 2017-03-09 2022-03-21 Evonik Operations Gmbh Medio de cultivo que comprende oligopéptidos
DE102017203908B3 (de) 2017-03-09 2018-05-30 Evonik Technochemie Gmbh Kulturmedium, umfassend Oligopeptide
ES2724434T3 (es) * 2017-03-09 2019-09-10 Evonik Technochemie Gmbh Medios de cultivo que comprenden dipéptidos de N-acil-X-glutamina
CA3058306A1 (en) * 2017-03-28 2018-10-04 Ajinomoto Co., Inc. Additive for undifferentiation maintaining medium
CN106978390B (zh) * 2017-05-22 2020-11-13 广东顺德工业设计研究院(广东顺德创新设计研究院) 适用于贴壁型cho细胞的无血清培养基及培养方法
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
CN107278892A (zh) * 2017-06-26 2017-10-24 浦江县美泽生物科技有限公司 紫玉兰的高效组织培养方法
SG11202003354VA (en) * 2017-10-13 2020-05-28 Boehringer Ingelheim Int Perfusion medium
US12480091B2 (en) * 2017-11-16 2025-11-25 Life Technologies Corporation Streamlined methods for making liquid media
KR20200100108A (ko) * 2017-12-20 2020-08-25 바스프 에스이 양친매성 그라프트 공중합체를 세포 배양 시약으로 이용하여 세포 배양 시스템을 안정화하는 방법
CN112352046A (zh) * 2018-06-29 2021-02-09 长濑产业株式会社 麦角硫因、抗坏血酸2-葡糖苷、抗坏血酸和它们的组合的成肌分化促进作用
JP7197339B2 (ja) 2018-12-05 2022-12-27 アサヒグループ食品株式会社 コク味付与物質含有酵母の製造方法及びコク味付与物質含有酵母エキスの製造方法
CN109628378B (zh) * 2019-01-25 2020-07-17 江苏丰华生物制药有限公司 一种利用花生蛋白酶解物培养cho细胞的方法
WO2021213822A1 (en) 2020-04-20 2021-10-28 Evonik Operations Gmbh Compositions comprising cys-peptides
GB202012991D0 (en) 2020-08-20 2020-10-07 Ucb Biopharma Sprl Cell culture processes
KR20240055110A (ko) * 2021-09-15 2024-04-26 에보닉 오퍼레이션스 게엠베하 디펩티드 및 미량 원소를 포함하는 조성물
KR20240073107A (ko) 2021-10-05 2024-05-24 에보닉 오퍼레이션스 게엠베하 디펩티드의 염 및 세포 배양에서의 이의 용도
AU2023227353B2 (en) 2022-03-03 2026-02-12 Evonik Operations Gmbh Process to enhance viral vector production in cell-culture using glycyl-glutamine
US20250064706A1 (en) * 2022-05-12 2025-02-27 Evonik Operations Gmbh Photostabilized compositions and a method for stabilizing photosensitive components
EP4665839A1 (en) * 2023-02-16 2025-12-24 Merck Patent GmbH Cell culture media
KR102609654B1 (ko) * 2023-03-23 2023-12-05 코스맥스 주식회사 인간 피부 유래 산물을 포함하는 미생물 배양 배지 및 이를 이용하여 배양된 혼합 미생물 배양액의 피부 개선 용도
GB202318647D0 (en) 2023-12-06 2024-01-17 Ucb Biopharma Sprl Cell culture processes
WO2025219232A1 (en) * 2024-04-15 2025-10-23 Evonik Operations Gmbh Application of small peptides supplemented cell culture media for improved cell performance
CN118956737A (zh) * 2024-07-17 2024-11-15 广州沃亘生物科技有限公司 一种长期维持df-1细胞活力的培养基及其用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130195A1 (en) * 2000-01-27 2003-07-10 Universite Laval Enzymatic hydrolysate of milk proteins
WO2008035631A1 (fr) * 2006-09-20 2008-03-27 Kyowa Hakko Kogyo Co., Ltd. Procédé de production d'une substance
WO2008141207A1 (en) * 2007-05-11 2008-11-20 Amgen Inc. Improved feed media

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235772A (en) * 1978-06-21 1980-11-25 Ab Kabi Novel peptides having growth promoting activity
DE3206810C2 (de) 1982-02-25 1983-12-29 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen N ↑2↑-L-Tyrosinyl-N ↑6↑-L-tyrosinyl-L-lysin und N ↑2↑-L-Cystinyl-N ↑6↑-L-cystinyl-L-lysin, Verfahren zu deren Herstellung und deren Verwendung
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
AU6521986A (en) * 1985-10-22 1987-05-19 Plant Genetics, Inc. Methods and media for enhanced somatic embryogenesis
DE3538310A1 (de) 1985-10-28 1987-04-30 Pfrimmer Pharma Verwendung von glutamin in form seiner di- und tripeptide im naehrmedium fuer zellkulturen
AU605214B2 (en) * 1986-10-24 1991-01-10 Fresenius Kabi Ab N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
US5206220A (en) 1990-04-23 1993-04-27 Research Corporation Technologies, Inc. Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
CA2081023A1 (en) * 1990-04-23 1991-10-24 Mary A. Hilton Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
US5328844A (en) * 1990-05-09 1994-07-12 University Of Colorado Foundation, Inc. Culture media for mammalian cells
DE4022267C2 (de) 1990-07-12 1994-09-15 Degussa N-Acyldipeptide und deren Verwendung
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB2251249B (en) 1990-12-28 1995-06-21 Mogam Biotech Res Inst High-density medium for animal cell culture
WO1996026266A1 (en) * 1995-02-23 1996-08-29 Quest International B.V. Peptides for tissue and cell culture media
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
US6759510B1 (en) 2000-06-30 2004-07-06 Becton, Dickinson And Company Peptides for use in culture media
AU2002234591A1 (en) * 2000-12-20 2002-07-01 Novartis Ag Inhibitors of the e2f-1/cyclin interaction for cancer therapy
US20030096414A1 (en) 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
MXPA04005010A (es) * 2001-11-26 2005-04-08 Advanced Cell Tech Inc METODO PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS METODOS PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS HUMANOS REPROGRAMADOS Y CELULAS DEL TALLO HUMANAS AUTOLOGAS E ISOGENICAS.
WO2003085138A1 (en) 2002-03-29 2003-10-16 Merck & Co., Inc. Methods of virus production
US7332303B2 (en) * 2002-12-23 2008-02-19 Bristol-Myers Squibb Company Product quality enhancement in mammalian cell culture processes for protein production
US7193038B2 (en) * 2003-02-28 2007-03-20 National Institute Of Agrobiological Sciences Extraction and utilization of cell growth-promoting peptides from silk protein
US20050287666A1 (en) 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
JP2007521832A (ja) * 2004-09-07 2007-08-09 クロネックス・ディベロップメント・インコーポレイテッド 細胞培養からのタンパク質収量の増加において使用するための細胞株
RU2007127719A (ru) * 2004-12-20 2009-01-27 Адзиномото Ко., Инк. (Jp) Мутантный белок, имеющий пептидсинтезирующую активность
MX353340B (es) * 2006-09-13 2018-01-09 Abbvie Inc Mejoras de cultivos celulares.
KR101464783B1 (ko) * 2006-09-15 2014-11-26 메디뮨 엘엘씨 높은 역가로 바이러스 증식을 지원하는 ｍｄｃｋ 세포주 및 이를 이용한 생물반응기 공정
CA2668771C (en) * 2006-11-08 2016-03-15 Wyeth Rationally designed media for cell culture
JP5576115B2 (ja) 2007-04-26 2014-08-20 中外製薬株式会社 高濃度アミノ酸含有培地を用いた細胞の培養方法
JP2008276843A (ja) 2007-04-27 2008-11-13 Hitachi Ltd レーザー駆動方法及び光ディスク記録再生装置
EP2173860A1 (en) 2007-08-03 2010-04-14 Campina Nederland Holding B.V. Culture medium for eukaryotic cells
JP4911523B2 (ja) * 2007-10-22 2012-04-04 国立大学法人群馬大学 温度応答性配列を含むデプシペプチド構造と親水性高分子構造からなるブロック共重合体
WO2009060620A1 (ja) * 2007-11-08 2009-05-14 Fujifilm Corporation ポリペプチドの製造方法
JP5270239B2 (ja) 2008-07-08 2013-08-21 不二製油株式会社 ペプチド性脂質低下剤
EP2351833B1 (en) 2008-10-28 2018-07-18 Chugai Seiyaku Kabushiki Kaisha Peptide-containing culture medium for culturing animal cell
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
WO2012017925A1 (ja) * 2010-08-02 2012-02-09 協和発酵キリン株式会社 物質の製造方法
EP2601287B1 (en) * 2010-08-05 2015-01-07 Amgen Inc. Dipeptides to enhance yield and viability from cell cultures

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130195A1 (en) * 2000-01-27 2003-07-10 Universite Laval Enzymatic hydrolysate of milk proteins
WO2008035631A1 (fr) * 2006-09-20 2008-03-27 Kyowa Hakko Kogyo Co., Ltd. Procédé de production d'une substance
WO2008141207A1 (en) * 2007-05-11 2008-11-20 Amgen Inc. Improved feed media

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DRINGEN, R. et al., Journal of Neurochemistry, 1997, Vol. 69, No. 2, pages 868-874 *
IMAMOTO, Y. et al., Animal Cell Technology: Basic & Applied Aspects, 1 January 2010, pages 65-71 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10793827B2 (en) 2010-04-23 2020-10-06 Life Technologies Corporation Cell culture medium comprising small peptides
US11365389B2 (en) 2010-04-23 2022-06-21 Life Technologies Corporation Cell culture medium comprising small peptides
US12529029B2 (en) 2010-04-23 2026-01-20 Life Technologies Corporation Cell culture medium comprising small peptides

Also Published As

Publication number Publication date
SG10201609347RA (en) 2017-01-27
CN102892878A (zh) 2013-01-23
AU2016200611A1 (en) 2016-02-18
AU2011242496A1 (en) 2012-10-25
AU2016256736B2 (en) 2018-11-01
WO2011133902A2 (en) 2011-10-27
JP2013524817A (ja) 2013-06-20
JP7200180B2 (ja) 2023-01-06
AU2016256736A1 (en) 2016-12-01
EP3168295A1 (en) 2017-05-17
KR20170051527A (ko) 2017-05-11
KR102109463B1 (ko) 2020-05-12
SG184936A1 (en) 2012-11-29
WO2011133902A3 (en) 2012-04-19
DE202011110859U1 (de) 2016-12-20
JP2017060496A (ja) 2017-03-30
AU2011242496B2 (en) 2015-11-19
US20170058256A1 (en) 2017-03-02
KR20180023019A (ko) 2018-03-06
EP4170016A1 (en) 2023-04-26
DK2561065T3 (en) 2017-02-13
US20200308537A1 (en) 2020-10-01
CN106520658A (zh) 2017-03-22
US20220275325A1 (en) 2022-09-01
KR101733834B1 (ko) 2017-05-08
EP2561065B1 (en) 2016-11-09
CN110205282A (zh) 2019-09-06
EP3165600B1 (en) 2022-11-02
KR20130106762A (ko) 2013-09-30
EP2561065A2 (en) 2013-02-27
US20170342371A1 (en) 2017-11-30
KR20170089027A (ko) 2017-08-02
US20110262965A1 (en) 2011-10-27
DK3165600T3 (da) 2022-12-05
DK3168295T3 (da) 2022-11-21
EP3165600A1 (en) 2017-05-10
KR20160138316A (ko) 2016-12-02
US11365389B2 (en) 2022-06-21
KR102264580B1 (ko) 2021-06-11
AU2018202222A1 (en) 2018-04-26
KR20200051847A (ko) 2020-05-13
JP2018113996A (ja) 2018-07-26
JP2022171839A (ja) 2022-11-11
AU2018202612A1 (en) 2018-05-10
JP6367293B2 (ja) 2018-08-01
US12529029B2 (en) 2026-01-20
US10793827B2 (en) 2020-10-06
AU2018202612B2 (en) 2020-10-29
AU2021200418B2 (en) 2023-05-25
US20230365919A1 (en) 2023-11-16
EP3168295B1 (en) 2022-11-02
JP2020137529A (ja) 2020-09-03
KR101832795B1 (ko) 2018-02-28
CN106520658B (zh) 2024-09-24
EP2561065A4 (en) 2013-07-03
SG10201503196VA (en) 2015-06-29
JP7481407B2 (ja) 2024-05-10
JP2017006127A (ja) 2017-01-12
JP2024099021A (ja) 2024-07-24
AU2021200418A1 (en) 2021-02-25
KR101831549B1 (ko) 2018-02-22
CN110205282B (zh) 2024-07-05
JP6016783B2 (ja) 2016-10-26

Similar Documents

Publication Publication Date Title
US12529029B2 (en) Cell culture medium comprising small peptides

Legal Events

Date Code Title Description
CB Opposition filed

Opponent name: BOROVEC, S.

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 19 OCT 2016

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 19 OCT 2016

CH Opposition withdrawn

Opponent name: BOROVEC, S.

FGA Letters patent sealed or granted (standard patent)